At 12 months, the average weight loss was 15.3% with GLP-1+GIP and 8.3% with GLP-1 agonists
Follow specific instructions before a drug test to avoid cross-reactivity
Clinical decisions should involve gastroenterology and diabetes specialists, with close monitoring of disease activity and nutritional status
Patients should be instructed to avoid touching multiple tablets when removing a single dose, as the moisture from hands could affect the remaining tablets
If anything, ongoing users report improvements in baseline digestive function, including more regular bowel movements, less bloating from meals in general, and better tolerance of diverse foods
Nawrocki can help identify the root trigger causing hair issues, recommend lab tests related to nutritional deficiency, thyroid disorders, or hormone imbalance, and advise treatment options like PRP injections to stimulate regrowth